Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Niles-Benton Harbor, MI MSA — September 2026
Niles labor force shrinks as life sci pay gap with national market widens.
Niles-Benton Harbor unemployment held at 4.2% even as the labor force fell 7.6% year-over-year, while Michigan's $37.98 average biotech/pharma hourly pay trails national CMC and regulatory compensation by a wide margin.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Niles MSA unemployment rate: 4.2% — vs 5.0% Michigan, 4.1% U.S.
- Niles labor force, YoY change: -7.6% — Shrinking pool despite stable unemployment
- Michigan biotech/pharma avg. hourly pay: $37.98 — Range $23.85-$47.29; trails national premiums
- Biopharma orgs actively recruiting nationally: 64% — Despite Sept. layoffs at BioMarin, Bristol Myers
Key takeaways
Labor force shrinkage, not weak demand, is the metro's real constraint.
Niles-Benton Harbor's labor force fell 7.6% year-over-year while unemployment held at a relatively tight 4.2%. For quality, manufacturing, and lab-support roles, this points toward a sourcing problem that compensation increases alone may not solve.
Michigan pay levels lag national life sci benchmarks by a wide margin.
Average biotech/pharma hourly pay in Michigan sits at $37.98, well below figures implied by national VP Regulatory Affairs ranges of $320K-$580K or Director CMC roles reaching $520K. Metro employers recruiting against coastal or national remote postings for senior regulatory and CMC talent should expect compensation friction, not just competition on culture or mission.
State apprenticeship investment signals a build, not buy, response to manufacturing gaps.
Michigan's proposed $2.06 million BioWorkforce Apprenticeship Program targets GMP, cleanroom, and aseptic processing skills for non-degreed talent. This is a direct response to the same manufacturing workforce shortage affecting Niles-area plants, and may create a near-term internal pipeline option for quality and production headcount planning.
National selective hiring pattern likely extends to this metro's smaller employers.
Sixty-four percent of surveyed biopharma organizations report active recruiting even amid September layoffs at BioMarin and Bristol Myers, with cuts concentrated in consolidation functions rather than execution-critical roles. Niles-area employers should expect continued competition for regulatory, quality, and CMC talent even as layoff headlines suggest a cooling market.
Median advertised pay by role — Niles-Benton Harbor, MI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $95,062 | $133,986 | $152,750 | Significant increase | $131,354 |
| Clinical Research Associate * | $71,571 | $98,354 | $104,246 | Significant increase | $90,956 |
| Lab Technician * | $37,668 | $44,932 | $46,933 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $68,607 | $95,340 | $114,031 | Significant decline | $104,000 |
| Clinical Data Manager * | $97,759 | $128,800 | $150,000 | Significant decline | $123,031 |
| Biostatistician * | $111,515 | $131,971 | $156,868 | Stable | $133,322 |
| Validation Engineer * | $77,591 | $100,880 | $110,300 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Niles-Benton Harbor's unemployment rate held at 4.2% in September, tighter than Michigan's 5.0% statewide reading, even as the metro's labor force contracted 7.6% year-over-year — a shrinking candidate pool, not softening demand, appears to be the binding constraint. Manufacturing remains the metro's largest employer base at 13,370 workers, but statewide biomanufacturing and biosciences talent programs are emerging specifically because employers can't source skilled production and quality talent locally.
What it means
Local wage data trails national benchmarks badly — Michigan biotech/pharma hourly pay averages $37.98 against a national regulatory and CMC talent market commanding six-figure premiums for scarce specialties — meaning Niles-area employers competing for regulatory, quality, or CMC talent are effectively bidding against Boston- and APAC-anchored compensation structures with a Midwest cost base. A shrinking regional labor force combined with statewide apprenticeship investment in GMP and cleanroom skills suggests manufacturing and quality headcount plans should lean on build-your-own-pipeline strategies rather than assuming open-market hiring will fill gaps. Consider evaluating whether current manufacturing and quality technician compensation reflects the structural labor force contraction here, not just statewide or national survey averages.
Looking ahead
Early indicator: Watch whether Michigan's year-over-year labor force contraction in the Niles metro stabilizes or deepens through Q4; continued decline would tighten sourcing further for manufacturing and quality roles regardless of posted wage levels.
Potential inflection point: Track state budget action on the $2.06 million BioWorkforce Apprenticeship Program funding request. Approval would create a credentialed non-degreed talent pipeline directly relevant to GMP and cleanroom headcount planning in Southwest Michigan.
Worth watching: National biopharma layoffs (BioMarin, Bristol Myers) concentrated in consolidation roles bear monitoring for any ripple into Michigan sites; released talent entering the regional pool could ease pressure on quality and regulatory hiring if it materializes.
Emerging pressure point: Michigan's statewide unemployment rose to 5.0% on a shrinking workforce rather than job losses — a structural divergence from national trends. If this pattern persists into the Niles metro, expect continued upward pressure on offers for roles requiring cleanroom or validation credentials.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.